MNKD vs REGN: Which Stock is Better?
Side-by-side comparison of MannKind Corp and Regeneron Pharmaceuticals Inc in 2026
MNKD
MannKind Corp
$5.49
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | MNKD | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.56B | $77.77B | REGN |
| P/E Ratio | 50.70 | 17.58 | REGN |
| EPS (TTM) | $0.10 | $41.75 | REGN |
| Revenue Growth | 0.2% | 0.0% | MNKD |
| Gross Margin | 75.2% | 45.8% | MNKD |
Analyze MNKD
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNKD or REGN a better investment?
Comparing MNKD and REGN: MannKind Corp has a market cap of $1.56B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNKD and REGN?
MNKD (MannKind Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNKD or REGN?
Based on P/E ratios, REGN trades at a lower multiple (17.6x vs 50.7x).
Which is growing faster: MNKD or REGN?
MNKD has higher revenue growth at 0.2% vs 0.0% for REGN.
Which company is more profitable: MNKD or REGN?
MannKind Corp (MNKD) has higher gross margins at 75.2% compared to 45.8% for REGN.
Which is the larger company: MNKD or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $1.56B for MNKD.
Should I buy MNKD or REGN in 2026?
Both MNKD and REGN have investment merit. MNKD trades at $5.49 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNKD and REGN stock?
Key differences: Market Cap ($1.56B vs $77.77B), P/E Ratio (50.7x vs 17.6x), Revenue Growth (0.2% vs 0.0%), Gross Margin (75.2% vs 45.8%).